MEI5 partners with Sae3 to form an evolutionarily conserved complex essential for homologous recombination (HR) during meiosis . Key functions include:
Dmc1 activation: Mei5-Sae3 facilitates Dmc1 filament assembly on single-stranded DNA (ssDNA), enabling strand exchange during double-strand break (DSB) repair .
RPA interaction: The complex binds replication protein A (RPA) to counteract its inhibitory effects on Dmc1 .
Conservation: Human SWI5-MEI5 (homologous to Mei5-Sae3) directly interacts with RAD51 to promote HR repair in mitotic cells .
Antibodies against MEI5 have been generated to investigate its localization, protein interactions, and functional domains:
Studies using mei5 mutants (e.g., Arg97Ala) revealed residues critical for:
Complex stability: Arg97 in Mei5 is essential for Sae3 binding .
DNA binding: Basic residues in α-helices mediate ssDNA/dsDNA binding .
Dmc1 filament stabilization: Mei5-Sae3 displaces RPA from ssDNA, allowing Dmc1 to catalyze strand exchange .
Post-translational regulation: The Mei5-R117A mutation induces truncation, altering Dmc1-mediated recombination .
Cross-species functionality: Human SWI5-MEI5 rescues HR defects in yeast, highlighting conserved mechanisms .
Specificity: Anti-Mei5 antibodies reliably distinguish full-length and truncated forms (e.g., in mei5-R117A) .
Cross-reactivity: Human SWI5-MEI5 antibodies detect conserved epitopes but require validation for species-specific applications .
Limitations: Mei5-Sae3 expression is meiosis-specific in yeast, necessitating synchronized meiotic cultures for optimal detection .
Cancer therapeutics: Human SWI5-MEI5’s role in RAD51-mediated HR positions it as a potential target for sensitizing tumors to radiation .
Infertility research: Defective Mei5-Sae3 complexes correlate with meiotic arrest, offering insights into gametogenesis disorders .
Structural studies: Cryo-EM of Mei5-Sae3-Dmc1 complexes could reveal allosteric activation mechanisms.
Therapeutic discovery: High-throughput screens using MEI5 antibodies may identify small-molecule modulators of HR.
KEGG: sce:YPL121C
STRING: 4932.YPL121C
MEI5 is a protein that forms a complex with Sae3 in Saccharomyces cerevisiae and functions during homologous recombination. The Mei5-Sae3 complex preferentially binds single-stranded DNA and relieves the inhibition of the meiotic recombinase Dmc1 imposed by replication protein A (RPA) . This complex is essential for proper meiotic progression and has been shown to physically interact with RPA, suggesting its role in coordinating the handoff of single-stranded DNA from RPA to the recombinase .
Methodologically, researchers studying MEI5 function typically use biochemical assays such as co-immunoprecipitation to verify protein-protein interactions and DNA binding assays to assess functional activity.
The choice depends on the experimental objective:
Polyclonal MEI5 antibodies: Useful for detecting the protein across multiple species due to recognition of multiple epitopes. Best for initial protein characterization, immunoprecipitation, and applications where signal amplification is needed.
Monoclonal MEI5 antibodies: Provide higher specificity for a single epitope, reducing background and cross-reactivity. Ideal for distinguishing between closely related proteins or specific protein domains.
For validation, apply complementary strategies similar to those used for other antibodies, including Western blot, immunohistochemistry, immunofluorescence, and flow cytometry as appropriate to your experimental model .
MEI5 antibody validation should follow these methodological approaches:
| Validation Method | Purpose | Controls | Expected Results |
|---|---|---|---|
| Western Blot | Confirm molecular weight and specificity | Recombinant MEI5, MEI5-knockout sample | Single band at expected molecular weight |
| Immunoprecipitation | Verify antigen capture ability | IgG control, pre-immune serum | Specific pull-down of MEI5 and associated proteins |
| Peptide Competition | Confirm epitope specificity | Blocking peptide | Reduced or eliminated signal |
| Dot Blot | Rapid specificity testing | Recombinant MEI5 and related proteins | Signal only for MEI5 protein |
For comprehensive validation, employ complementary strategies as recommended for antibody validation principles, including using knockout or knockdown systems to confirm specificity .
When using MEI5 antibodies for immunofluorescence:
Negative controls: Include secondary antibody-only controls to assess background and non-specific binding
Positive controls: Use samples with known MEI5 expression patterns
Blocking controls: Pre-incubate the antibody with immunizing peptide to confirm specificity
Cellular localization validation: Compare localization patterns with published data on MEI5 distribution during meiosis
For optimal results, validate your MEI5 antibody using protocols consistent with immunofluorescence conditions, as an antibody that shows specificity in Western blot may not necessarily perform well in immunofluorescence applications .
MEI5 antibodies can be strategically employed to investigate its interactions with partner proteins:
Co-immunoprecipitation (Co-IP): Use MEI5 antibodies to pull down the Mei5-Sae3 complex and analyze interacting partners by mass spectrometry or Western blot. Evidence shows that MEI5 co-immunoprecipitates with Sae3, confirming their direct interaction .
Proximity Ligation Assay (PLA): Detect in situ interactions between MEI5 and candidate proteins such as RPA or Dmc1 in intact cells.
ChIP-sequencing: Map MEI5 binding sites on chromatin during meiotic recombination, particularly at sites where single-stranded DNA binding activity is critical.
In experimental design, consider timing of sample collection during meiosis, as MEI5-Sae3 complex formation and activity are likely temporally regulated during recombination processes.
To investigate potential post-translational modifications (PTMs) of MEI5:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| Phospho-specific antibodies | Detect phosphorylated MEI5 | High specificity for modified sites | Requires development of site-specific antibodies |
| Mass spectrometry | Global PTM analysis | Comprehensive identification of multiple PTMs | Requires protein purification and specialized equipment |
| Phos-tag SDS-PAGE | Mobility shift detection | Simple technique to detect phosphorylation | Cannot identify specific sites |
| PTM-specific peptide arrays | Map antibody specificity to modified sites | High-throughput screening | Limited to known modification sites |
For antibody validation in PTM studies, peptide arrays and competitive ELISAs are particularly useful to determine specificity for modified versus unmodified protein forms, as demonstrated for other PTM-specific antibodies .
Multiple bands in MEI5 Western blots may result from:
Alternative splicing variants: Verify known MEI5 isoforms in your model system
Post-translational modifications: Different phosphorylation states can cause mobility shifts
Protein degradation: Optimize sample preparation with appropriate protease inhibitors
Cross-reactivity: Validate antibody specificity using peptide competition assays
To troubleshoot, perform dot blot analysis similar to that described for other antibodies . Dot a dilution series of recombinant MEI5 protein alongside potential cross-reactive proteins to assess specificity and optimal antibody concentration.
Optimization strategies include:
Antigen retrieval method selection: Compare heat-induced epitope retrieval methods (citrate buffer pH 6.0 vs. EDTA buffer pH 9.0)
Antibody concentration titration: Test serial dilutions to determine optimal signal-to-noise ratio
Incubation conditions: Compare different temperatures (4°C, room temperature) and durations (1 hour, overnight)
Signal amplification systems: Evaluate tyramide signal amplification for low-abundance targets
Validate specificity using peptide competition, where the antibody is pre-incubated with immunizing peptide prior to staining, as demonstrated for other antibodies in IHC applications .
MEI5 antibodies can serve as valuable tools for investigating meiotic defects:
Timing of MEI5 localization: Normal meiosis shows specific temporal patterns of MEI5 recruitment to recombination sites
Co-localization with recombination markers: MEI5 should properly co-localize with Dmc1 and other recombination proteins
Quantitative analysis: Compare MEI5 foci number and intensity in normal versus mutant conditions
Design experiments to track the Mei5-Sae3 complex formation and its interaction with Dmc1 and RPA during meiotic progression, as these interactions are critical for mediating recombinase loading onto single-stranded DNA .
When applying MEI5 antibodies across species:
Sequence homology analysis: Compare MEI5 sequence homology between the immunogen and your target species
Epitope conservation: Check if the antibody targets conserved epitopes
Validation in target species: Always validate antibodies in your specific model organism
Cross-reactivity testing: Test for cross-reactivity with related proteins in your experimental system
While the Mei5-Sae3 complex has been well-characterized in Saccharomyces cerevisiae , researchers should carefully validate antibodies when studying homologs in other organisms.
When faced with contradictory results:
Antibody epitope consideration: Different antibodies may recognize distinct protein domains with varying accessibility in different applications
Experimental conditions: Compare fixation methods, buffers, and detection systems
Protein conformation effects: Native versus denatured conditions can affect epitope recognition
Quantitative validation: Use multiple antibodies and techniques to reach consensus
Remember that even with high-quality antibodies, results can vary between applications. As noted for other antibodies, "an antibody that displays exquisite specificity by western blot may be nonspecific in an immunohistochemistry assay or ineffective in a functional assay" .
For quantitative analysis of MEI5 imaging data:
Foci counting and categorization: Establish clear criteria for MEI5 foci identification
Colocalization analysis: Use Pearson's or Mander's coefficients for MEI5 colocalization with partner proteins
Intensity measurements: Normalize MEI5 signal intensity to appropriate controls
Time-course analysis: Apply regression models to track MEI5 dynamics during meiotic progression
Statistical verification should include assessment of inter-observer reliability, particularly for manual counting methods, and appropriate sample sizes with power calculations.